Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

The National Agency for the Control of AIDS (NACA), Global Network of Young People Living with HIV (Y+ Global), and the Joint ...

A Chinese research team has isolated an antibody from alpacas that can effectively inhibit HIV, providing a promising avenue ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...

Spread This News Despite high rates of untreated osteoporosis and previous fractures among menopausal women in Zimbabwe — ...

Despite high rates of untreated osteoporosis and previous fractures among menopausal women in Zimbabwe -- especially among those living with human immunodeficiency virus (HIV) -- the FRAX® tool ...

But in terms of HIV preventions, there is already another groundbreaking drug called lenacapavir. The anti-HIV compound is already in use, but getting the drug to those who need it most could ...

Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle ...

LGBTQ group says Uganda has lost potentially up to $1.6 billion in GDP following the passage of a law criminalizing ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...